A decent representation at BIO-Europe

Attending events like BIO-Europe comes with several benefits for young companies. They will have the chance to showcase their solutions to an international audience, learn about the latest industry trends from biotech and pharma leaders, have personal meetings, and meet potential partners, investors or customers.

Innosuisse gives start-ups with global ambitions the chance to attend international trade fairs as exhibitors. The start-ups at BIO-Europe supported by Innosuisse will present the following solutions:

Cellestia Biotech AG – first-in-class gene therapies for autoimmune diseases and multi-drug resistant cancers.

cellvie AG – therapeutic mitochondria transplantation, a novel treatment approach aimed at the cellular energy metabolism

InCephalo AG – next-generation therapies for brain cancers based on its proprietary Compartment Lock technology, also called C-Lock

IsoSpec Analytics SA – uses infrared spectroscopy to build the next generation of mass spectrometers using molecular fingerprints to Identify analytes, accelerating the development of biotech products and enabling the discovery of new biomarkers

MPC Therapeutics  – cellular rejuvenation to fight cancer and degenerative pathologies

Nagi Bioscience SA – developed the first device that allows fully automated and standardized substance testing on micro-organisms, thus replacing animal testing

NXI Therapeutics AG – novel therapy for autoimmunity and organ transplantation

RisKlick SA – first data-driven AI solution for optimizing clinical trial protocols

Synendos Therapeutics AG – a new class of small molecules for treating a wide range of Central Nervous System (CNS) disorders

Topadur Pharma AG - portfolio of drug candidates to treat aging-related diseases like chronic wounds, skin fibrosis, age-related macular degeneration, colorectal cancer, hair loss and skin aging.

Vandria SA – Mitophagy inducers to treat age-related and chronic diseases

In total 28 exhibitors will be present at the Swiss Pavilion in Munich. These include some well known older companies such as Bioversys, Insphero and Molecular Partners but also some additional young companies like Healiva (precision medicine for chronic wounds) and Muvon (tissue engineering platform for the regeneration of skeletal muscles).

(RAN / SK)